Upcoming Webinar to Examine Oncology in the Era of Value Frameworks: Perspectives From Payers and Oncologists & Implications for Product Planning

TORONTO, ON --(Marketwired - November 25, 2015) - Breakthrough advances in oncology have produced a multitude of new treatment options, often with substantial clinical gains attached to significantly higher pricing. This rapidly evolving treatment landscape has ushered in attempts to quantify and compare the incremental value of new products, such as the American Society for Clinical Oncology (ASCO) Conceptual Framework to Assess the Value of Cancer Treatment Options. Manufacturers of oncology drugs must be prepared to present new and existing oncology products within the context of these frameworks, ensuring that the value of products is appropriately and fully characterized.

Join featured speakers, Douglas Neely, Senior Director at Xcenda, and Lisa Bloudek, Assistant Director at Xcenda, as they discuss how these frameworks are currently perceived through sharing of comprehensive survey data from oncologists and payers. Additionally, the speakers will share strategies on how these frameworks can be leveraged by manufacturers to demonstrate product value, with a focus on the ASCO framework.

Key takeaway points:

--  Gain insights from oncologists and payers on the impact of value
    frameworks
--  Understand how oncologists and payers interpret the frameworks,
    including strengths and areas for improvement
--  Learn how oncology products will measure up under these frameworks, with
    implications for data generation in clinical trials and beyond 

The live broadcast takes place on Thursday, December 10, 2015 at 1pm EST. For more information or to register for this free webinar visit: Oncology in the Era of Value Frameworks: Perspectives from Payers and Oncologists & Implications for Product Planning.

About Xcenda

Xcenda is a strategic consulting firm with 20 years of experience applying real-world expertise in health economics and outcomes research, reimbursement, health policy, market research, and market access strategy. We support global pharmaceutical companies as well as emerging pre-commercialization phase firms with challenges such as developing an evidence package to optimize access in key global markets, predicting product performance, and identifying reimbursement strategies and programs to maximize patient access. From development through market maturity, Xcenda helps manufacturers identify, demonstrate, and deliver their brand's value proposition to key healthcare stakeholders.

Xcenda is backed by an even wider breadth of healthcare knowledge and partnerships through AmerisourceBergen Corporation ABC, one of the world's largest pharmaceutical services companies. Xcenda's strategic consulting services support the design of patient support services and specialty distribution programs to improve product access and adherence at every stage of its life cycle. For more information visit http://www.xcenda.com/.

About Xtalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx


Image Available: http://www.marketwire.com/library/MwGo/2015/11/24/11G073426/Images/Xcenda_CMYK_(1)-301466508781.JPG


FOR FURTHER INFORMATION PLEASE CONTACT:

Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com